ADDV B Stock Overview
Supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
ADDvise Group AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 3.42 |
52 Week High | SEK 15.06 |
52 Week Low | SEK 3.27 |
Beta | 0.39 |
11 Month Change | -43.18% |
3 Month Change | -42.41% |
1 Year Change | -63.28% |
33 Year Change | -56.88% |
5 Year Change | 326.88% |
Change since IPO | -7.70% |
Recent News & Updates
Recent updates
Shareholder Returns
ADDV B | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | -15.7% | -5.8% | -2.4% |
1Y | -63.3% | -7.8% | 10.9% |
Return vs Industry: ADDV B underperformed the Swedish Medical Equipment industry which returned -9.7% over the past year.
Return vs Market: ADDV B underperformed the Swedish Market which returned 10.8% over the past year.
Price Volatility
ADDV B volatility | |
---|---|
ADDV B Average Weekly Movement | 9.2% |
Medical Equipment Industry Average Movement | 7.3% |
Market Average Movement | 5.5% |
10% most volatile stocks in SE Market | 11.2% |
10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: ADDV B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: ADDV B's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 643 | Staffan Torstensson | www.addvisegroup.se |
ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The Lab business unit provides laboratory furnishings, ventilation, climate/clean rooms, and laboratory equipment to pharmaceutical and life science research industries. It is also involved in design, construction, and installation of clean rooms.
ADDvise Group AB (publ) Fundamentals Summary
ADDV B fundamental statistics | |
---|---|
Market cap | SEK 752.08m |
Earnings (TTM) | SEK 114.40m |
Revenue (TTM) | SEK 1.63b |
17.1x
P/E Ratio1.2x
P/S RatioIs ADDV B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ADDV B income statement (TTM) | |
---|---|
Revenue | SEK 1.63b |
Cost of Revenue | SEK 716.70m |
Gross Profit | SEK 917.20m |
Other Expenses | SEK 802.80m |
Earnings | SEK 114.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 20, 2025
Earnings per share (EPS) | 0.58 |
Gross Margin | 56.14% |
Net Profit Margin | 7.00% |
Debt/Equity Ratio | 218.4% |
How did ADDV B perform over the long term?
See historical performance and comparison